Brief: Active Biotech Q2 Loss After Tax Widens To SEK 14.3 Mln

Active Biotech AB publ

04/08/2022 07:40

Aug 4 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * Q2 LOSS AFTER TAX SEK 14,3 MILLION VERSUS LOSS SEK 12,6
MILLION
YEAR AGO
    * Q2 OPERATING LOSS SEK 14,0 MILLION VERSUS LOSS SEK 12,6
MILLION
YEAR AGO
    * BOARD OF DIRECTORS RESOLVED ON AUGUST 4, 2022 TO CARRY OUT
RIGHTS ISSUE OF ABOUT SEK 55 MILLION TO SECURE FINANCING OF
ONGOING AND PLANNED DEVELOPMENT PROGRAMS

Source text for Eikon:  ID:nMFN6PBwH8 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))